GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Gelteq Ltd
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 17, 2025
$0.43−0.02 (-3.50%)
Close on Oct 19, 2026
Gelteq Ltd revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | FY2023 | % of revenue |
|---|---|---|---|
| United States | A$125.65K | A$79.84K | 75.9% |
| Australia [Member] | A$40.00K | – | 24.1% |
From the segment and revenue-disaggregation notes of Gelteq's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.